Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R7 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R6 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R8 - Effective October 1, 2024 Sep 12, 2024
Self-Administered Drug Exclusion List (A53032) - R38 - Effective June 4, 2015 Sep 12, 2024
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update (A54386) - R11 - Effective October 1, 2024 Sep 05, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R13 - Effective September 5, 2024 Sep 05, 2024
Intervertebral Disc Repair - Published for Review and Comments Aug 29, 2024
Open Meeting Announcement Intervertebral Disc Repair - October 7, 2024 Aug 29, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720)- R20 - Effective October 1, 2024 Aug 29, 2024
Open Meeting Announcement - Multiple MolDX Policies MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis and MolDX: Genetic Testing for Heritable Thoracic Aortic Disease - October 10, 2024 Aug 29, 2024